Physician
Gronli, Jerome
Gronli, Jerome was paid $2.58M by Medicaid between Jan 2018 and Dec 2024, across 56 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 23% of everything it billed.
33Billing provider infoGRONLI, JEROME
NAPERVILLE, IL 60563
NAPERVILLE, IL 60563
33aNPI1235464165assigned 10/09/2009
33bProvider typePediatrics Physician
28Total paid$2.58M
24GClaims61,288
24DCodes billed56
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Illinois
Rank by total paid#29 of 1,805
Median peer was paid$55K
This provider vs. median47×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 3,615 | $146K | |
| 2019 | 6,894 | $290K | |
| 2020 | 6,506 | $245K | |
| 2021 | 8,064 | $323K | |
| 2022 | 12,240 | $543K | |
| 2023 | 11,908 | $509K | |
| 2024incomplete | 12,061 | $524K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 23% | 7,683 | 6,392 | $592K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 19% | 9,923 | 8,211 | $497K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 8.5% | 2,886 | 2,163 | $220K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 8.5% | 1,545 | 1,302 | $220K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 6.9% | 2,344 | 1,987 | $177K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 6.3% | 1,969 | 1,660 | $163K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 5.7% | 2,151 | 1,621 | $148K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 1.9% | 2,113 | 1,931 | $49K |
| D1206 | Topical application of fluoride varnish | 1.8% | 1,804 | 1,482 | $47K |
| 96127 | 1.8% | 2,593 | 2,223 | $46K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.7% | 1,274 | 915 | $45K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 1.4% | 2,326 | 1,863 | $37K |
44 more codes
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.1% | 1,208 | $29K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 1.0% | 641 | $26K |
| 96160 | 1.0% | 1,784 | $26K | |
| 92551 | <1% | 1,661 | $25K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,597 | $25K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 597 | $25K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 57 | $20K |
| 90651 | <1% | 819 | $18K | |
| 90698 | <1% | 1,426 | $18K | |
| 90686 | <1% | 1,612 | $16K | |
| 90670 | <1% | 1,071 | $14K | |
| 83655 | <1% | 1,174 | $14K | |
| 90671 | <1% | 506 | $10K | |
| 90674 | <1% | 530 | $9K | |
| 99173 | <1% | 1,145 | $9K | |
| 90680 | <1% | 597 | $8K | |
| 85018 | <1% | 2,339 | $5K | |
| 99174 | <1% | 584 | $4K | |
| 90734 | <1% | 224 | $4K | |
| 90661 | <1% | 215 | $4K | |
| 36416 | <1% | 859 | $4K | |
| 90633 | <1% | 271 | $3K | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 185 | $3K |
| 90619 | <1% | 161 | $3K | |
| 90716 | <1% | 83 | $2K | |
| 90620 | <1% | 145 | $2K | |
| 90744 | <1% | 196 | $2K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 144 | $2K |
| 92015 | Determination of refractive state | <1% | 103 | $2K |
| 90707 | <1% | 72 | $2K | |
| 90656 | <1% | 78 | $1K | |
| 90700 | <1% | 110 | $1K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 23 | $1K |
| 90647 | <1% | 39 | $489.84 | |
| 81002 | <1% | 175 | $455.00 | |
| 91321 | <1% | 18 | $435.23 | |
| 90713 | <1% | 33 | $414.48 | |
| 90685 | <1% | 40 | $298.40 | |
| 83718 | <1% | 26 | $208.52 | |
| 90715 | <1% | 12 | $200.52 | |
| 90696 | <1% | 18 | $115.20 | |
| 90710 | <1% | 18 | $115.20 | |
| 82465 | <1% | 26 | $110.24 | |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 0% | 55 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.